Countries citing papers authored by Robert J. Stratta
Since
Specialization
Citations
This map shows the geographic impact of Robert J. Stratta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Stratta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Stratta more than expected).
Fields of papers citing papers by Robert J. Stratta
This network shows the impact of papers produced by Robert J. Stratta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Stratta. The network helps show where Robert J. Stratta may publish in the future.
Co-authorship network of co-authors of Robert J. Stratta
This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Stratta.
A scholar is included among the top collaborators of Robert J. Stratta based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Robert J. Stratta. Robert J. Stratta is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 641–3.7 indexed citations
6.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 635–7.8 indexed citations
7.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 679–88.19 indexed citations
8.
Klintmalm, G, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. 25(1). 635–637.7 indexed citations
9.
Klintmalm, G, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. 25(1). 679–688.13 indexed citations
Shaw, Byers W., Rodney S. Markin, Robert J. Stratta, et al.. (1991). FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.. PubMed. 23(6). 2994–5.15 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.